Previous 10 |
Sophisticated pharma investors will need to review the IGM Biosciences ( IGMS )' preclinical data. Janus Capital Management acquired shares, and the company holds a significant amount of cash. It means that preclinical research impressed institutional investors and may impress others. Having s...
Novartis (NYSE: NVS ) announces positive data from two Phase 3 clinical trials, ASCLEPIOS I and ASCLEPIOS II , evaluating monthly injections of ofatumumab versus daily oral doses of teriflunomide [Sanofi's (NASDAQ: SNY ) Aubagio] in adult patients with relapsing forms of multiple sclero...
Japan's Ministry of Health, Labor and Welfare approves Johnson & Johnson (NYSE: JNJ ) unit Janssen Biotech's Darzalex (daratumumab), combined with Takeda's Velcade (bortezomib), melphalan and prednisone, for newly diagnosed multiple myeloma (MM) patients who are ineligible for autologo...
Genmab A/S (NASDAQ: GMAB ) initiated with Overweight rating and $30 (58% upside) price target at Morgan Stanley. Initiated with Outperform rating and $23 price target at RBC. Shares up 1% premarket. More news on: Genmab A/S, Fulcrum Therapeutics, Inc., Mirum Pharmaceuticals, In...
A Kansas bank and a Chinese fintech are scheduled for the week ahead, the last crop of offerings before the IPO market's annual August break. CrossFirst Bankshares (CFB) has about $4.6 billion in assets, with seven locations across KS, OK, TX, and MO. While its efficiency ratio and ROE are b...
News, Short Squeeze, Breakout and More Instantly...
2024-08-01 01:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
A look at the top 10 most actives in the United States Innovative Eyewear Inc. (LUCY) rose 78.0% to $0.58749 on volume of 130,454,575 shares Ocean Power Technologies Inc. (OPTT) rose 29.6% to $0.2073 on volume of 51,927,154 shares Cosmos Health Inc. (COSM) rose 64.9% to $1.12 on volume of...
Company Announcement Positive CHMP opinion based on results from the Phase 1/2 EPCORE ® NHL-1 study FL is the second most common type of NHL and accounts for approximately 20-30 percent of all global cases If approved, epcoritamab (TEPKINLY ® ...